MA38169B2 - Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux - Google Patents

Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux

Info

Publication number
MA38169B2
MA38169B2 MA38169A MA38169A MA38169B2 MA 38169 B2 MA38169 B2 MA 38169B2 MA 38169 A MA38169 A MA 38169A MA 38169 A MA38169 A MA 38169A MA 38169 B2 MA38169 B2 MA 38169B2
Authority
MA
Morocco
Prior art keywords
disease
ciclesonide
horses
treatment
respiratory tract
Prior art date
Application number
MA38169A
Other languages
English (en)
Other versions
MA38169A1 (fr
Inventor
Balazs Albrecht
Michael Aven
Janine Lamar
Ingo Lang
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA38169(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of MA38169A1 publication Critical patent/MA38169A1/fr
Publication of MA38169B2 publication Critical patent/MA38169B2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne le domaine de la médecine, en particulier le domaine de la médecine vétérinaire. La présente invention concerne des glucocorticoïdes, en particulier le ciclésonide ou un dérivé pharmaceutiquement acceptable de celui-ci, pour le traitement d'une maladie des voies respiratoires chez les chevaux, telles qu'une maladie pulmonaire, de préférence l'obstruction récurrente des voies respiratoires (rao), la maladie pulmonaire obstructive associée aux pâturages d'été (spaopd), et une maladie inflammatoire des voies respiratoires (iad).
MA38169A 2012-12-21 2013-12-18 Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux MA38169B2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
PCT/EP2013/077265 WO2014096115A1 (fr) 2012-12-21 2013-12-18 Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux

Publications (2)

Publication Number Publication Date
MA38169A1 MA38169A1 (fr) 2017-01-31
MA38169B2 true MA38169B2 (fr) 2021-08-31

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38169A MA38169B2 (fr) 2012-12-21 2013-12-18 Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux

Country Status (24)

Country Link
US (4) US9918995B2 (fr)
EP (1) EP2934479B1 (fr)
AR (1) AR094241A1 (fr)
AU (2) AU2013360691B2 (fr)
BR (2) BR112015010842B1 (fr)
CA (1) CA2888428C (fr)
CY (2) CY1121115T1 (fr)
DK (1) DK2934479T3 (fr)
ES (1) ES2693779T3 (fr)
FR (1) FR20C1026I1 (fr)
HR (1) HRP20181980T1 (fr)
HU (1) HUS2000020I1 (fr)
IN (1) IN2015DN02894A (fr)
LT (2) LT2934479T (fr)
MA (1) MA38169B2 (fr)
MX (1) MX368306B (fr)
NO (1) NO2020014I1 (fr)
NZ (1) NZ706573A (fr)
PL (1) PL2934479T3 (fr)
PT (1) PT2934479T (fr)
RS (1) RS57740B1 (fr)
SI (1) SI2934479T1 (fr)
WO (1) WO2014096115A1 (fr)
ZA (1) ZA201502288B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013024036A1 (fr) 2011-08-12 2013-02-21 Boehringer Ingelheim Vetmedica Gmbh Inhibiteurs du drôle de courant (courant if) destinés à être utilisés dans un procédé de traitement et de prévention de l'insuffisance cardiaque chez les félins
BR112015010842B1 (pt) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
ES2759247T3 (es) 2014-06-18 2020-05-08 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos
WO2018070819A1 (fr) * 2016-10-14 2018-04-19 제주대학교 산학협력단 Composition comprenant du ciclésonide destinée à inhiber la croissance de cellules souches cancéreuses
WO2021140113A1 (fr) * 2020-01-10 2021-07-15 Boehringer Ingelheim Vetmedica Gmbh Ciclésonide pour améliorer la qualité de vie (qol) chez les équidés
US20230270754A1 (en) 2020-07-31 2023-08-31 Chemo Research, S.L. Combination therapy for inhalation administration

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
WO2004023984A2 (fr) 2002-09-13 2004-03-25 Smith C Steven Composition et procede pour le traitement des affections des voies respiratoires superieures
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
PT1670482E (pt) 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
CA2568834A1 (fr) 2004-06-29 2006-01-12 Boehringer Ingelheim International Gmbh Medicaments pour inhalation comprenant des steroides et un anticholinergique
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
JP2012530567A (ja) 2009-06-25 2012-12-06 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入器
US7829748B1 (en) 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
WO2014007767A1 (fr) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalateurs de poudre sèche comprenant un excipient autre que le lactose et un composant ternaire
EA201590019A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
LT3473255T (lt) 2012-12-21 2022-03-10 Boehringer Ingelheim Vetmedica Gmbh Farmacinė vaisto forma, apimanti ciklezonidą
BR112015010842B1 (pt) 2012-12-21 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos
HRP20201987T1 (hr) 2013-08-20 2021-02-05 Boehringer Ingelheim Vetmedica Gmbh Inhalator
EP3035885B1 (fr) 2013-08-20 2019-12-25 Boehringer Ingelheim Vetmedica GmbH Inhalateur
ES2759247T3 (es) 2014-06-18 2020-05-08 Boehringer Ingelheim Vetmedica Gmbh Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos

Also Published As

Publication number Publication date
SI2934479T1 (sl) 2019-01-31
ES2693779T3 (es) 2018-12-13
NO2020014I1 (no) 2020-06-12
BR112015010842B1 (pt) 2021-03-30
LT2934479T (lt) 2018-12-27
CA2888428A1 (fr) 2014-06-26
PL2934479T3 (pl) 2019-02-28
ZA201502288B (en) 2019-09-25
AU2018201642A1 (en) 2018-03-29
BR112015010842A2 (pt) 2017-07-11
MX368306B (es) 2019-09-27
DK2934479T3 (en) 2018-11-05
BR112015010842A8 (pt) 2019-10-01
US10441597B2 (en) 2019-10-15
HRP20181980T1 (hr) 2019-01-25
US10258634B2 (en) 2019-04-16
US20170079988A1 (en) 2017-03-23
BR122016029247A2 (pt) 2019-08-20
EP2934479B1 (fr) 2018-09-19
WO2014096115A1 (fr) 2014-06-26
MA38169A1 (fr) 2017-01-31
US20140179651A1 (en) 2014-06-26
EP2934479A1 (fr) 2015-10-28
PT2934479T (pt) 2018-12-20
LTPA2020511I1 (lt) 2020-07-27
US20180153907A1 (en) 2018-06-07
CY2020015I1 (el) 2020-11-25
NZ706573A (en) 2019-11-29
CA2888428C (fr) 2021-07-13
US20150313918A1 (en) 2015-11-05
CY1121115T1 (el) 2019-12-11
IN2015DN02894A (fr) 2015-09-11
AR094241A1 (es) 2015-07-22
US9918995B2 (en) 2018-03-20
AU2013360691A1 (en) 2015-04-16
AU2018201642B2 (en) 2019-01-31
MX2015007947A (es) 2015-10-08
AU2013360691B2 (en) 2018-03-08
CY2020015I2 (el) 2021-03-12
HUS2000020I1 (hu) 2020-07-28
FR20C1026I1 (fr) 2020-10-02
RS57740B1 (sr) 2018-12-31

Similar Documents

Publication Publication Date Title
MA38169A1 (fr) Ciclésonide pour le traitement d'une maladie des voies respiratoires chez les chevaux
EA031157B9 (ru) Вводимая перорально кортикостероидная композиция
MX2018002631A (es) Inhibidores de molecula pequeña de dyrkia y usos de los mismos.
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX2009005398A (es) Metodos para el tratamiento de enfermedades inflamatorias cronicas usando antagonista de gm-csf.
EP2582676A4 (fr) Modulateurs allostériques positifs du récepteur m1 de l'amide tétrahydroquinoline
PH12017500444A1 (en) Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia
EA201290519A1 (ru) Положительные аллостерические модуляторы рецептора хинолин амида m1
EP2666471A4 (fr) Composition pharmaceutique pour la traitement de la rate et de l'estomac, ainsi que procédé de préparation de cette composition
NZ625592A (en) Compositions and methods for the treatment of hepatic diseases and disorders
EA201001781A1 (ru) Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов
MX2019014935A (es) Antagonistas muscarinicos y sus combinaciones para el tratamiento de enfermedades de las vias respiratorias en caballos.
PH12016500746B1 (en) A novel formulation of meloxicam
RU2016132762A (ru) Фармацевтические композиции, содержащие 15-гэпк, и способы лечения астмы и заболеваний легких с их применением
TR201000733A2 (tr) Flutikazon, tiotropyum ve sodyum kromoglikat içeren farmasötik bileşimler.
WO2009134668A3 (fr) Modulateurs allostériques positifs pour le récepteur m1 de 4-oxo-1,4-dihydroquinoléine
MX350662B (es) Composiciones farmaceuticas que comprenden 7- (1h- imidazol-4-ilmetil) -5,6,7,8,-tetrahidroquinolina para el tratamiento de enfermedades y dolencias de la piel.
EP2431049A4 (fr) Préparation pharmaceutique destinée à être administrée dans des organes respiratoires pour le traitement ou la prévention de maladies respiratoires inflammatoires, et procédé de traitement ou de prévention de telles maladies
ATE522537T1 (de) (e)-n-ä3-ä1-(8-fluor-11h-10-oxa-1-aza-dibenzo-ä , dü-cyclohepten-5-yliden)-propylü-phenylü- methylsulfon-amid als glucocorticoid- rezeptormodulator zur behandlung rheumatoider arthritis
PH12015502560A1 (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
PH12016501119A1 (en) Zirconium silicate for treating hyperkalemia without co-administering lithium
FR2927256B1 (fr) Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation
FR2960780B1 (fr) Medicament pour le traitement de la maladie de parkinson
Wollin et al. PI3kinase Gamma Kinase Dead Knock-In Mice Are Protected Against Cigarette Smoke-Induced Pulmonary Inflammation